You can buy or sell CSII and other stocks, options, ETFs, and crypto commission-free!
Cardiovascular Systems, Inc. Common Stock, also called Cardiovascular Systems, is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. Read More It offers orbital atherectomy systems for both peripheral and coronary commercial applications. Its products are primarily catheter-based platforms capable of treating a range of vessel sizes and plaque types. The company was founded in 2000 and is headquartered in St. Paul, MN.
St. Paul, Minnesota
52 Week High
52 Week Low
Yahoo FinanceMar 14
Cardiovascular Systems Gains on Global Growth & Innovation
On Mar 11, we issued an updated research report on Cardiovascular Systems, Inc. CSII. The company has been pursuing product improvements and evaluating new technologies to strengthen and broaden its portfolio of powerful micro invasive tools. However, the company facing cut-throat competition is a concern. The stock currently carries a Zacks Rank #2 (Buy). Over the past three months, shares of Cardiovascular Systems have outperformed its industry. The stock has surged 47% compared with the industry’s 11.3%...
Simply Wall StMar 8
Did You Miss Cardiovascular Systems’s Whopping 304% Share Price Gain?
Generally speaking, investors are inspired to be stock pickers by the potential to find the big winners. You won’t get it right every time, but when you do, the returns can be truly splendid. Take, for example, the Cardiovascular Systems, Inc. (NASDAQ:CSII) share price, which skyrocketed 304% over three years. On top of that, the share price is up 38% in about a quarter. Check out our latest analysis for Cardiovascular Systems Given that Cardiovascular Systems only made minimal earnings in the last twelve...
Cardiovascular Systems, Inc. to Present at Three Upcoming Investor Conferences
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that management will present and host investor meetings at the following three conferences: Cowen 39th Annual Health Care Conference Monday, March 11, 2019 at 1:30 pm ET Barclays Global Healthcare Conference Tuesday, March 12, 2019 at 10:45 am ET ...
Expected May 1, After Hours